Climbers are searching for ways to climb the highest mountains in the world in shorter time periods, including the use of controversial substances.

This spring, a group of commercial climbers plan to summit Everest in just a week by chemically boosting their acclimatization using a new method.

In a trial featuring a mouse model of Alzheimer's, scientists found that inhaling a mixture containing xenon gas helped reduce levels of brain atrophy and neuroinflammation.

Alzheimer’s is the most common form of dementia — it causes memory loss, confusion, thinking problems and behavioral changes.

A former British army officer is attempting the 'fastest ever' Everest mission, with help from xenon gas. Everest could be scaled in less than a week, rather than the usual two months, and British pilot and former Gurkha officer, Garth Miller, is leading the first mission.

A breakthrough study highlights Xenon gas as a potential game-changer in treating Alzheimer’s disease, demonstrating its ability to mitigate brain damage and improve cognitive functions in mouse models.

The gas xenon, like the other noble, or inert, gases, is known for doing very little. The class of elements, because of its molecular structure, don’t typically interact with many chemicals.